Credits: None available.
Guidelines for determining the severity of hypertension as well as recommended treatments continue to change. This session answers your questions about the stages of hypertension, treatment guidelines, and nursing care indications.
Continuing Education Instructions and Disclosure Information
Contact hours available until 10/14/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee:
Marijo Johnson - Employee, Fresenius Medical Care
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Learning Outcome:
After completing this learning activity, the learner will describe the stages of hypertension and the guidelines for treatment and relate those to the medical and nursing care indications.
You must be logged in and own this session in order to post comments.
This is not the normal population group that I work with, but I found it a very interesting discussion of studies that support ACE/ARB usage for management of CV events as well as a very well narrated explanation of the various guidelines currently in practice. Two things I plan to learn more about are chlorthalidone and "dippers". I'm curious to see if what others in my organization know.
Patrice Hughes
2/15/20 2:00 pm
This provided a lot of great information. I had some questions answered about the benefits of evening BP meds.